These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23941202)

  • 1. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.
    King MK; Jope RS
    Genes Brain Behav; 2013 Oct; 12(7):723-31. PubMed ID: 23941202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.
    Franklin AV; King MK; Palomo V; Martinez A; McMahon LL; Jope RS
    Biol Psychiatry; 2014 Feb; 75(3):198-206. PubMed ID: 24041505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
    Liu ZH; Huang T; Smith CB
    Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
    Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism.
    Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS
    PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
    Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
    Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome.
    Pardo M; Beurel E; Jope RS
    Eur J Neurosci; 2017 Feb; 45(4):490-498. PubMed ID: 27775852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
    Liu ZH; Chuang DM; Smith CB
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):618-30. PubMed ID: 20497624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
    Brennan FX; Albeck DS; Paylor R
    Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
    Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
    Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
    Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
    Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agmatine relieves behavioral impairments in Fragile X mice model.
    Jeon SJ; Kwon H; Bae HJ; Gonzales EL; Kim J; Chung HJ; Kim DH; Ryu JH; Shin CY
    Neuropharmacology; 2022 Nov; 219():109234. PubMed ID: 36057317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice.
    Radwan B; Dvorak D; Fenton AA
    Neurobiol Dis; 2016 Apr; 88():125-38. PubMed ID: 26792400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired bidirectional NMDA receptor dependent synaptic plasticity in the dentate gyrus of adult female Fmr1 heterozygous knockout mice.
    Yau SY; Bostrom CA; Chiu J; Fontaine CJ; Sawchuk S; Meconi A; Wortman RC; Truesdell E; Truesdell A; Chiu C; Hryciw BN; Eadie BD; Ghilan M; Christie BR
    Neurobiol Dis; 2016 Dec; 96():261-270. PubMed ID: 27659109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome.
    Javadi S; Li Y; Sheng J; Zhao L; Fu Y; Wang D; Zhao X
    BMC Med; 2022 May; 20(1):163. PubMed ID: 35549943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.